EIN PressWire
Bookmark and Share You are in: Live Press Feed

Mesothelioma Cancer News: ITT sees drop in profits after asbestos charge

The global diversified manufacturing company saw a dip in third quarter profits after asbestos charge.

New York (Mesothelioma Cancer News) – Defense and industrial manufacturing company ITT Corporation saw a substantial decrease in third quarter profits after a charge for asbestos claim liability. As reported by Dow Jones Newswires, a $131 million asbestos liability charge has led to a 73 percent profit decrease for the conglomerate.As noted in the report, ITT stated Friday its net income fell from $216.3 million to $59 million in the quarter.

The $131 million has reportedly been set aside for asbestos claims over the next decade. The asbestos exposure claims are purportedly attributed to the sale of asbestos containing pumps prior to 1985, which contained gaskets and packaging not manufactured by ITT.ITT Chairman and Chief Executive Steve Loranger is quoted by Dow Jones Newswires as stating of the company’s performance amid the loss, “We believe the company is doing what is required to emerge from the current economic environment as a much stronger company.”

Mesothelioma Cancer News provides news and information for New York Mesothelioma Lawyers News Source: http://www.mesotheliomacancernews.com - Press Release Distribution
Send
Press Release
Submit a press release to leading journalists, decision-makers and industry specific professionals worldwide, prices start from only $49.95.

Choose from over 80 industry targets.

Benefits & Features

  • Distribution to Hundreds of News Publications, Partner Newswire Services & Journalists Worldwide
  • Industry and/or Country Targetting
  • Social Bookmarks for Greater Web 2.0 Distribution
  • Search Engine Optimized
  • RSS Distribution
  • Printer-friendly & PDF Versions
  • Archived for 1 year minimum

Distribution Partners

Receive premium distribution to our press release channels.

Send
Press Release

EIN News
© 2005-2010 IPD Group, Inc. All Rights Reserved. | User Agreement | Privacy Policy | Contact